Grant funded growth San a Health has secured notable funding including a $3.4M Department of Defense grant to study PTSD through early 2026, signaling validated interest in PTSD and trauma recovery applications that could open B2B sales avenues with military, veterans services, and healthcare providers.

PTSD research focus With a pivotal PTSD study underway and a 25-year research-backed digital audiovisual platform, there is a compelling sales narrative for vendors and institutions seeking non-pharmacological mental health interventions and neurofeedback tools for clinical trials or therapeutic programs.

Clinical validation path The FDA status indicates the product is not yet approved for medical conditions, suggesting opportunities to engage partner sites for clinical validation, pilot programs, and data partnerships to accelerate regulatory clearance and expand hospital or clinic adoption.

Health awards credibility Award recognition such as the Otto Award in Health and Digital Health award finalist status enhances credibility when approaching healthcare networks, insurers, and health tech accelerators as a differentiator in competitive bids.

UK and global reach Sana UK Ltd’s international activity, grants, and participation in industry events indicate a global market approach; sales teams can target European and global healthcare systems, research institutions, and wearable tech collaborations for remote recovery and neurostimulation solutions.